$1.54
-0.07-4.35%
At close: -
$1.50
-0.04-2.60%
After Hours: Mar 11, 4:01 PM EDT
Comments
Loading...
Nephros Stock Guidance | NASDAQ:NEPH | Benzinga
Nephros issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/04/2023 | NEPH | Nephros | Q1 | 2023 | — | — | — | $3.70M | $3.70M | $2.68M | Get Alert |
| 01/11/2023 | NEPH | Nephros | Q4 | 2022 | — | — | — | $2.60M | $2.60M | $2.80M | Get Alert |
| 01/11/2023 | NEPH | Nephros | FY | 2022 | — | — | — | $10.00M | $10.00M | $10.25M | Get Alert |
| 10/11/2022 | NEPH | Nephros | Q3 | 2022 | — | — | — | $2.50M | $2.50M | $2.83M | Get Alert |
| 07/06/2022 | NEPH | Nephros | Q2 | 2022 | — | — | — | $2.90M | $2.90M | $2.52M | Get Alert |
| 02/23/2022 | NEPH | Nephros | FY | 2022 | — | — | — | $13.00M | $13.50M | $13.52M | Get Alert |
| 01/11/2022 | NEPH | Nephros | FY | 2021 | — | — | — | $10.40M | $10.40M | $10.59M | Get Alert |
| 01/11/2022 | NEPH | Nephros | Q4 | 2021 | — | — | — | $2.80M | $2.80M | $2.96M | Get Alert |
| 01/11/2022 | NEPH | Nephros | FY | 2022 | — | — | — | $13.00M | $13.50M | $15.66M | Get Alert |
| 10/08/2021 | NEPH | Nephros | Q3 | 2021 | — | — | — | $2.60M | $2.60M | $2.93M | Get Alert |
| 07/08/2021 | NEPH | Nephros | Q2 | 2021 | — | — | — | $2.20M | $2.20M | $2.80M | Get Alert |
| 04/05/2021 | NEPH | Nephros | Q1 | 2021 | — | — | — | $2.70M | $2.70M | $2.35M | Get Alert |
| 01/12/2021 | NEPH | Nephros | Q4 | 2020 | — | — | — | $2.30M | $2.30M | $2.31M | Get Alert |
| 01/12/2021 | NEPH | Nephros | FY | 2020 | — | — | — | $8.50M | $8.50M | $8.56M | Get Alert |
| 10/06/2020 | NEPH | Nephros | Q3 | 2020 | — | — | — | $2.10M | $2.10M | $2.18M | Get Alert |
| 07/08/2020 | NEPH | Nephros | Q2 | 2020 | — | — | — | $1.60M | $1.60M | $2.24M | Get Alert |
FAQ
What is the most recent guidance for Nephros (NEPH)?
There have been no specific sales or earnings guidance reported for Nephros in recent months.
Browse guidance and forecast on all stocks.